1887

Abstract

Inappropriate use of antibiotics and inadequate therapeutic regimens for early-stage pulmonary infections are major contributors to increased prevalence of complications and mortality. Moreover, due to the limitations in sensitivity of conventional testing, there is an urgent need for more diagnostically efficient methods for the detection and characterization of pathogens in pulmonary infections.

Metagenomic next-generation sequencing (mNGS) can contribute to the diagnosis and management of pulmonary infections.

This study aimed to evaluate the clinical application and value of mNGS in the diagnosis of clinically suspected pulmonary infections by comparing with conventional testing.

In this study, the diagnosis performance of mNGS was evaluated using bronchoalveolar lavage fluid (BALF) samples from 143 patients with suspected lung infections. First, we conducted a prospective study on 31 patients admitted to Yuebei People’s Hospital Affiliated to Shantou University Medical College to investigate the clinical value. Then a retrospective analysis was performed by including more patients (=112) to reduce the random error. Pathogens were detected by mNGS and conventional methods (culture and PCR). Then, the types and cases of detected pathogens, as well as the specificity and sensitivity, were compared between the two methods. We evaluated the performance of mNGS in detecting bacterial, fungal, viral and mixed infections in BALF. The effect of disease severity in pulmonary infections on the integrity of mNGS pathogen detection was also explored.

The mNGS provided an earlier and more comprehensive pathogen profile than conventional testing, which in turn prompted a change in clinical medication, which led to improvement in eight patients (8/31=25.81 %) in the presence of other serious comorbidities. In a retrospective analysis, mNGS was much more sensitive than conventional testing in the diagnosis of pulmonary infections (95.33 % vs. 55.56 %; <0.001), with a 39.77 % increase in sensitivity. The detection rate of mNGS for mixed infections was significantly higher than that of conventional testing methods for both common and severe pneumonia (48/67=71.64 % vs. 12/52=23.08 %, <0.001; 44/59=74.58 % vs. 11/59=18.64 %, <0.0001).

The sensitivity of mNGS in the diagnosis of pathogenic microorganisms in pulmonary infections far exceeds that of conventional culture tests. As a complementary method to conventional methods, mNGS can help improve the diagnosis of pulmonary infections. In addition, mNGS pathogen integrity detection rate was similar in common and severe pneumonia. We recommend the prompt use of mNGS when mixed or rare pathogen infections are suspected, especially in immunocompromised individuals and/or critically ill individuals.

Funding
This study was supported by the:
  • Research Project for Outstanding Scholar of Yuebei People's Hospital, Shantou University Medical College, China (Award RS202001)
    • Principle Award Recipient: ZhaoPingsen
  • Research Fund for Joint Laboratory for Digital and Precise Detection of Clinical Pathogens, Yuebei People's Hospital Affiliated to Shantou University Medical College, China (Award KEYANSHEN (2023) 01)
    • Principle Award Recipient: ZhaoPingsen
  • Shaoguan Engineering Research Center for Research and Development of Molecular and Cellular Technology in Rapid Diagnosis of Infectious Diseases and Cancer Program, China (Award 20221807)
    • Principle Award Recipient: ZhaoPingsen
  • Shaoguan Municipal Science and Technology Program, China (Award 220610154531525)
    • Principle Award Recipient: ZhaoPingsen
  • Shaoguan Municipal Science and Technology Program, China (Award 211102114530659)
    • Principle Award Recipient: ZhaoPingsen
  • Natural Science Foundation of Guangdong Province, China (Award 2021A1515012429)
    • Principle Award Recipient: ZhaoPingsen
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001808
2024-02-29
2024-04-28
Loading full text...

Full text loading...

References

  1. Huang F, Cai X, Hou X, Zhang Y, Liu J et al. A dynamic covalent polymeric antimicrobial for conquering drug-resistant bacterial infection. Exploration 2022; 2:20210145 [View Article] [PubMed]
    [Google Scholar]
  2. Gao GF, Hoffmann JA, Walzer C, Lu J. Global public health crisis response: a roundtable discussion with Professor George Fu Gao, Professor Jules A Hoffmann, Professor Chris Walzer and Professor Jiahai Lu. hLife 2023; 1:63–70 [View Article]
    [Google Scholar]
  3. Ellwanger JH, Kaminski V de L, Chies JAB. Emerging infectious disease prevention: where should we invest our resources and efforts?. J Infect Public Health 2019; 12:313–316 [View Article] [PubMed]
    [Google Scholar]
  4. Shi G-Q, Yang L, Shan L-Y, Yin L-Z, Jiang W et al. Investigation of the clinical significance of detecting PTX3 for community-acquired pneumonia. Eur Rev Med Pharmacol Sci 2020; 24:8477–8482 [View Article] [PubMed]
    [Google Scholar]
  5. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for, edicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637–644 [View Article] [PubMed]
    [Google Scholar]
  6. X-Q Shi LT, Huang ZH, Song WT, Wu JB, Chen LM. Metagenomic next-generation sequencing vs. conventional detection methods for detecting the pulmonary infections. Eur Rev Med Pharmacol Sci 2023; 27:4752–4763
    [Google Scholar]
  7. Lin WV, Kruse RL, Yang K, Musher DM. Diagnosis and management of pulmonary infection due to Rhodococcus equi. Clin Microbiol Infect 2019; 25:310–315 [View Article] [PubMed]
    [Google Scholar]
  8. Riquelme SA, Prince A. Airway immunometabolites fuel Pseudomonas aeruginosa infection. Respir Res 2020; 21:326 [View Article] [PubMed]
    [Google Scholar]
  9. Meyerholz DK, Beck AP. Histopathologic evaluation and scoring of viral lung infection. Methods Mol Biol 2020; 2099:205–220 [View Article] [PubMed]
    [Google Scholar]
  10. Álvarez Artero E, Campo Núñez A, Garcia Bravo M, García García I, Belhassen Garcia M et al. Utility of the blood culture in infection of the urinary tract with fever in the elderly. Rev Esp Quimioter 2021; 34:249–253 [View Article] [PubMed]
    [Google Scholar]
  11. Fabre V, Carroll KC, Cosgrove SE, Humphries RM. Blood culture utilization in the hospital setting: a call for diagnostic stewardship. J Clin Microbiol 2022; 60:e0100521 [View Article] [PubMed]
    [Google Scholar]
  12. Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD et al. Infectious diseases study group for respiratory V: how to interpret and use COVID-19 serology and immunology tests. Clin Microbiol Infect 2021; 27:981–986
    [Google Scholar]
  13. Selyutina A, Diaz-Griffero F. Biochemical detection of capsid in the nucleus during HIV-1 infection. STAR Protoc 2021; 2:100323 [View Article] [PubMed]
    [Google Scholar]
  14. Huang H-S, Tsai C-L, Chang J, Hsu T-C, Lin S et al. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clin Microbiol Infect 2018; 24:1055–1063 [View Article] [PubMed]
    [Google Scholar]
  15. Chen X, Liu C, Li F, Zhou J, Huang Z et al. Rapid and visual detection of monkey B virus based on recombinase polymerase amplification. Zoonoses 2023; 3: [View Article]
    [Google Scholar]
  16. Zinter MS, Dvorak CC, Mayday MY, Iwanaga K, Ly NP et al. Pulmonary metagenomic sequencing suggests missed infections in immunocompromised children. Clin Infect Dis 2019; 68:1847–1855 [View Article] [PubMed]
    [Google Scholar]
  17. Lin Z, Sun L, Wang C, Wang F, Wang J et al. Bottlenecks and recent advancements in detecting Mycobacterium tuberculosis in patients with HIV. iLABMED 2023; 1:44–57 [View Article]
    [Google Scholar]
  18. Guo F, Kang L, Zhang L. mNGS for identifying pathogens in febrile neutropenic children with hematological diseases. Int J Infect Dis 2022; 116:85–90 [View Article] [PubMed]
    [Google Scholar]
  19. Zhang Y, Huang Q, Zhou Z, Xie Y, Li X et al. Prognosis of severe lower respiratory tract infected patients with virus detected: a retrospective observational study. Infect Dis 2021; 53:600–606 [View Article] [PubMed]
    [Google Scholar]
  20. Forbes JD, Knox NC, Ronholm J, Pagotto F, Reimer A. Metagenomics: the next culture-independent game changer. Front Microbiol 2017; 8:1069 [View Article] [PubMed]
    [Google Scholar]
  21. Diao Z, Han D, Zhang R, Li J. Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections. J Adv Res 2022; 38:201–212 [View Article] [PubMed]
    [Google Scholar]
  22. Wang Y, Zhang A, Wei X, Zhang Z, Bi X et al. Metagenomic next-generation sequencing identified psittacosis among poultry processing workers in Shandong Province, China. Infect Med 2022; 1:135–139 [View Article] [PubMed]
    [Google Scholar]
  23. Han D, Li Z, Li R, Tan P, Zhang R et al. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol 2019; 45:668–685 [View Article] [PubMed]
    [Google Scholar]
  24. Shi Y, Peng JM, Qin HY, Du B. Metagenomic next-generation sequencing: a promising tool for diagnosis and treatment of suspected pneumonia in rheumatic patients with acute respiratory failure: Retrospective cohort study. Front Cell Infect Microbiol 2022; 12:941930 [View Article] [PubMed]
    [Google Scholar]
  25. Nisar MK, Ostör AJK. Pulmonary complications of biological therapies in children and adults with rheumatic diseases. Paediatr Respir Rev 2013; 14:236–241 [View Article] [PubMed]
    [Google Scholar]
  26. Wingard JR, Hiemenz JW, Jantz MA. How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation. Blood 2012; 120:1791–1800 [View Article] [PubMed]
    [Google Scholar]
  27. Toma I, Siegel MO, Keiser J, Yakovleva A, Kim A et al. Single-molecule long-read 16S sequencing to characterize the lung microbiome from mechanically ventilated patients with suspected pneumonia. J Clin Microbiol 2014; 52:3913–3921 [View Article] [PubMed]
    [Google Scholar]
  28. Xie Y, Du J, Jin W, Teng X, Cheng R et al. Next generation sequencing for diagnosis of severe pneumonia: China, 2010-2018. J Infect 2019; 78:158–169 [View Article] [PubMed]
    [Google Scholar]
  29. Li N, Ma X, Zhou J, Deng J, Gu C et al. Clinical application of metagenomic next-generation sequencing technology in the diagnosis and treatment of pulmonary infection pathogens: a prospective single-center study of 138 patients. J Clin Lab Anal 2022; 36:e24498 [View Article] [PubMed]
    [Google Scholar]
  30. Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis 2018; 66:778–788 [View Article] [PubMed]
    [Google Scholar]
  31. Zhao H, Zhao Y, Yan N, Wang Y, Li W et al. Metagenomic next-generation sequencing of bronchoalveolar lavage fluid in non-severe and severe pneumonia patients. J Microbiol Methods 2023; 215:106848 [View Article] [PubMed]
    [Google Scholar]
  32. Chen S, Kang Y, Li D, Li Z. Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in patients with pulmonary infections: systematic review and meta-analysis. Int J Infect Dis 2022; 122:867–873 [View Article] [PubMed]
    [Google Scholar]
  33. Qian Y-Y, Wang H-Y, Zhou Y, Zhang H-C, Zhu Y-M et al. Improving pulmonary infection diagnosis with metagenomic next generation sequencing. Front Cell Infect Microbiol 2020; 10:567615 [View Article] [PubMed]
    [Google Scholar]
  34. Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol 2019; 20:1279–1290 [View Article] [PubMed]
    [Google Scholar]
  35. Chen X, Ding S, Lei C, Qin J, Guo T et al. Blood and bronchoalveolar lavage fluid metagenomic next-generation sequencing in pneumonia. Can J Infect Dis Med Microbiol 2020; 2020:1–9 [View Article] [PubMed]
    [Google Scholar]
  36. Yang A, Chen C, Hu Y, Zheng G, Chen P et al. Application of metagenomic next-generation sequencing (mNGS) using bronchoalveolar lavage fluid (BALF) in diagnosing pneumonia of children. Microbiol Spectr 2022; 10:e0148822 [View Article] [PubMed]
    [Google Scholar]
  37. Qu J, Zhang J, Chen Y, Huang Y, Xie Y et al. Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China. Emerg Microbes Infect 2022; 11:556–566 [View Article] [PubMed]
    [Google Scholar]
  38. Wu X, Li Y, Zhang M, Li M, Zhang R et al. Etiology of severe community-acquired pneumonia in adults based on metagenomic next-generation sequencing: a prospective multicenter study. Infect Dis Ther 2020; 9:1003–1015 [View Article] [PubMed]
    [Google Scholar]
  39. Yang J, Gong Y, Zhang C, Sun J, Wong G et al. Co-existence and co-infection of influenza a viruses and coronaviruses: public health challenges. Innovation 2022; 3:100306 [View Article] [PubMed]
    [Google Scholar]
  40. Liu H, Zhang Y, Yang J, Liu Y, Chen J. Application of mNGS in the etiological analysis of lower respiratory tract infections and the prediction of drug resistance. Microbiol Spectr 2022; 10:e0250221 [View Article] [PubMed]
    [Google Scholar]
  41. Bakaletz LO. Viral-bacterial co-infections in the respiratory tract. Curr Opin Microbiol 2017; 35:30–35 [View Article] [PubMed]
    [Google Scholar]
  42. Han D, Yu F, Zhang D, Yang Q, Xie M et al. The real-world clinical impact of plasma mNGS testing: an observational study. Microbiol Spectr 2023; 11:e0398322 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001808
Loading
/content/journal/jmm/10.1099/jmm.0.001808
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error